首页> 外文期刊>Nucleic acids research >Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo
【24h】

Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo

机译:Atelocollagen介导的合成小干扰RNA递送,可在体内外有效地沉默基因

获取原文
           

摘要

Silencing gene expression by siRNAs is rapidly becoming a powerful tool for the genetic analysis of mammalian cells. However, the rapid degradation of siRNA and the limited duration of its action call for an efficient delivery technology. Accordingly, we describe here that Atelocollagen complexed with siRNA is resistant to nucleases and is efficiently transduced into cells, thereby allowing long-term gene silencing. Site-specific in vivo administration of an anti-luciferase siRNA/Atelocollagen complex reduced luciferase expression in a xenografted tumor. Furthermore, Atelocollagen-mediated transfer of siRNA in vivo showed efficient inhibition of tumor growth in an orthotopic xenograft model of a human non-seminomatous germ cell tumor. Thus, for clinical applications of siRNA, an Atelocollagen-based non-viral delivery method could be a reliable approach to achieve maximal function of siRNA in vivo.
机译:siRNA沉默基因表达正迅速成为哺乳动物细胞遗传分析的有力工具。然而,siRNA的快速降解及其作用的持续时间有限,要求一种有效的递送技术。因此,我们在这里描述了与siRNA复合的Atelocollagen对核酸酶具有抗性,并且可以有效地转导到细胞中,从而允许长期的基因沉默。对萤光素酶siRNA / Atelocollagen复合体进行位点特异性体内给药可降低异种移植肿瘤中萤光素酶的表达。此外,Atelocollagen介导的siRNA在体内的转移在人类非精原细胞生殖细胞肿瘤的原位异种移植模型中显示出对肿瘤生长的有效抑制。因此,对于siRNA的临床应用,基于Atelocollagen的非病毒递送方法可能是在体内实现siRNA的最大功能的可靠方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号